276
Participants
Start Date
January 20, 2020
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
ABSK021
ABSK021 oral capsule
COMPLETED
The Winship Cancer Institute of Emory University, Atlanta
COMPLETED
MD Anderson Cancer Center, Houston
RECRUITING
Precision NextGen Oncology, Beverly Hills
COMPLETED
SCRI at HealthOne, Denver
RECRUITING
Beijing Jishuitan Hospital, Beijing
RECRUITING
The First Affiliated Hospital of Sun Yat-sen University, Guangdong
COMPLETED
Hebei Medical University Third Hospital, Shijiazhuang
RECRUITING
Henan Cancer Hospital, Zhengzhou
COMPLETED
The First Affiliated Hospital of Zhengzhou Universtity, Zhengzhou
ACTIVE_NOT_RECRUITING
Jiangsu Province Hospital, Nanjing
RECRUITING
Nanjing Drum Tower Hospital, Nanjing
COMPLETED
Liaoning Cancer Hospital, Shenyang
COMPLETED
Huashan Hospital of Fudan University, Shanghai
COMPLETED
Shanghai Sixth People's Hospital, Shanghai
RECRUITING
Xi'an Hong Hui Hospital, Xian
RECRUITING
West China Hospital of Sichuan University, Chengdu
RECRUITING
The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou
Lead Sponsor
Abbisko Therapeutics Co, Ltd
INDUSTRY